 The Centers for Disease Control and Prevention (CDC), the
Association of American Cancer Institutes (AACI), and the American Cancer
Society (ACS) are partnering to recognize immunization providers who are
successfully preventing HPV cancers, through timely vaccination of their young
adolescent patient population.
The program will serve to motivate
clinicians to adopt effective recommendation practices, and help educate
clinicians on the individual- and practice-level changes that can improve rates.
By recognizing clinicians with high HPV vaccine rates, we hope the program also
serves to reinforce for parental audiences that HPV vaccination is an important
part of cancer prevention and a normal part of adolescent immunization.
|
Clinicians,
clinics, practices, groups, and/or health systems can be nominated for the HPV
Vaccine Is Cancer Prevention Champion Award if they are effectively working to
protect their adolescent patients against HPV cancers by achieving high HPV
vaccination completion rates. Each year, the award program will honor up to one
Champion from each of the 10 U.S. Department of Health and Human Services (HHS)
regions.
Champions
will be selected based on the following criteria and considerations:
- Nominee must be a clinician, clinic, practice,
group, or health system
- Nominee must reach target series completion rate
of 70% for the patient population aged 13–15 years. The rate must account for
both female and male patients. Vaccination under the two-dose schedule (two
doses given at least five months apart in children ages 9–14 years) satisfies
series completion, as does the original three--‐dose schedule.
- Patient population size will be considered.
Patient population is defined as patients who have had a clinical encounter
with the nominee in the previous 24 months.
- Data provided via AFIX (Assessment, Feedback,
Incentives, and eXchange) can be used for nomination. Other data sources can
include immunization information systems, electronic health record platforms,
quality improvement initiatives, or performance measure systems, but that data
must be validated by the state or local immunization.
-
Submissions must be received by September 15,
2017.
 |
Once submissions are received, a CDC review panel will
evaluate all nominations. The panel will select up to one awardee from each of
the 10 HHS regions based on the listed criteria and considerations. AACI and
ACS will approve each awardee selection, and then, the organizations will
co-issue the awards. Champions will be announced in October 2017.
Champions will be featured on
CDC’s website and in the #PreteenVaxNews
e-newsletter, will receive an HPV Vaccine
Is Cancer Prevention Champion plaque, and may be recognized at local or national events led by cancer
prevention or pediatric health organizations.
 Want to know more? Learn more about the HPV Vaccine is Cancer Prevention Champion Award and nominate a Champion today at www.cdc.gov/hpv/champions
| 
